HCA Healthcare annual ebitda
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
HCA Healthcare EBITDA Growth & History (HCA)
HCA Healthcare's calculated EBITDA was $13.36B for fiscal 2025.
View full HCA Healthcare company overviewHCA Healthcare annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $13.36B | $1.52B | +12.84% |
| 2024 | 2024-12-31 | $11.84B | $1.05B | +9.76% |
| 2023 | 2023-12-31 | $10.78B | −$766.0M | −6.63% |
| 2022 | 2022-12-31 | $11.55B | −$1.14B | −8.96% |
| 2021 | 2021-12-31 | $12.69B | $4.54B | +55.64% |
| 2020 | 2020-12-31 | $8.15B | $311.0M | +3.97% |
| 2019 | 2019-12-31 | $7.84B | $227.0M | +2.98% |
| 2018 | 2018-12-31 | $7.61B | $1.10B | +16.91% |
| 2017 | 2017-12-31 | $6.51B | −$264.0M | −3.90% |
| 2016 | 2016-12-31 | $6.78B | — | — |
HCA Healthcare quarterly ebitda
Q2.17
Q3.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $4.04B | $759.0M | +23.15% |
| Q1 2026 | 2026-03-31 | $3.22B | $30.0M | +0.94% |
| Q4 2025 | 2025-12-31 | $3.58B | $594.0M | +19.87% |
| Q3 2025 | 2025-09-30 | $3.31B | $559.0M | +20.34% |
| Q2 2025 | 2025-06-30 | $3.28B | $222.0M | +7.26% |
| Q1 2025 | 2025-03-31 | $3.19B | $145.0M | +4.77% |
| Q4 2024 | 2024-12-31 | $2.99B | −$145.0M | −4.63% |
| Q3 2024 | 2024-09-30 | $2.75B | $349.0M | +14.55% |
| Q2 2024 | 2024-06-30 | $3.06B | $484.0M | +18.82% |
| Q1 2024 | 2024-03-31 | $3.04B | $364.0M | +13.59% |
| Q4 2023 | 2023-12-31 | $3.13B | −$918.0M | −22.66% |
| Q3 2023 | 2023-09-30 | $2.40B | −$54.0M | −2.20% |
| Q2 2023 | 2023-06-30 | $2.57B | $74.0M | +2.96% |
| Q1 2023 | 2023-03-31 | $2.68B | $132.0M | +5.18% |
| Q4 2022 | 2022-12-31 | $4.05B | $738.0M | +22.27% |
| Q3 2022 | 2022-09-30 | $2.45B | −$1.42B | −36.66% |
| Q2 2022 | 2022-06-30 | $2.50B | −$331.0M | −11.70% |
| Q1 2022 | 2022-03-31 | $2.55B | −$124.0M | −4.64% |
| Q4 2021 | 2021-12-31 | $3.31B | $580.0M | +21.21% |
| Q3 2021 | 2021-09-30 | $3.87B | $2.19B | +130.26% |
| Q2 2021 | 2021-06-30 | $2.83B | $578.0M | +25.68% |
| Q1 2021 | 2021-03-31 | $2.67B | $1.19B | +79.92% |
| Q4 2020 | 2020-12-31 | $2.73B | $433.0M | +18.82% |
| Q3 2020 | 2020-09-30 | $1.68B | $56.0M | +3.44% |
| Q2 2020 | 2020-06-30 | $2.25B | $417.0M | +22.74% |
| Q1 2020 | 2020-03-31 | $1.48B | −$595.0M | −28.62% |
| Q4 2019 | 2019-12-31 | $2.30B | $231.0M | +11.16% |
| Q3 2019 | 2019-09-30 | $1.63B | −$25.0M | −1.51% |
| Q2 2019 | 2019-06-30 | $1.83B | $34.0M | +1.89% |
| Q1 2019 | 2019-03-31 | $2.08B | −$13.0M | −0.62% |
| Q4 2018 | 2018-12-31 | $2.07B | — | — |
| Q3 2018 | 2018-09-30 | $1.65B | $334.0M | +25.36% |
| Q2 2018 | 2018-06-30 | $1.80B | $119.0M | +7.08% |
| Q1 2018 | 2018-03-31 | $2.09B | — | — |
| Q3 2017 | 2017-09-30 | $1.32B | — | — |
| Q2 2017 | 2017-06-30 | $1.68B | — | — |
HCA Healthcare ebitda trends
Over the last five fiscal years, HCA Healthcare's ebitda increased from $8.15B to $13.36B, a change of $5.20B. The latest reported quarter, Q2 2026, shows $4.04B.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review HCA Healthcare source filings ↗